Chantal Petit

Chantal brings more than two decades of experience in biopharma working on small molecules, biologics, and AAV gene therapies from discovery through commercialization. She most recently was Chief of Staff to the Chief Scientific Officer and the Research division at PTC Therapeutics Inc. Prior to that she was the program/alliance management lead at Provention Bio; product development lead at Regenxbio; project leader at Shire and GlaxoSmithKline; and senior investigator at Smithkline Beecham, leading research in the antimicrobial field.

Chantal earned a Ph.D. in microbiology and biochemistry from the University of Nancy, France. She completed post-doctoral training in Canada and the UK, as well as a Certificate in Clinical Trial Management from Temple University.